We are live on ! Find out more
ZP

Zimmer Partners Portfolio holdings

AUM $4.15B
1-Year Est. Return 14.2%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+14.2%
3 Year Est. Return
+57.21%
5 Year Est. Return
+47.82%
10 Year Est. Return
+152.76%
AUM
$7.43B
AUM Growth
+$64.4M
Cap. Flow
-$131M
Cap. Flow %
-1.76%
Top 10 Hldgs %
34.22%
Holding
242
New
74
Increased
35
Reduced
42
Closed
70

Sector Composition

Rank Sector Weight
1 Real Estate 33.23%
2 Utilities 31.12%
3 Communication Services 8.54%
4 Energy 8.13%
5 Industrials 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSA icon
151
Public Storage
PSA
$60.2B
$1.02M 0.01%
+3,386
New +$950K
BZ icon
152
Kanzhun
BZ
$6.89B
$991K 0.01%
+25,000
New +$961K
CFLT
153
DELISTED
Confluent
CFLT
$950K 0.01%
+20,000
New +$967K
GRCL
154
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$910K 0.01%
70,000
FTS icon
155
Fortis
FTS
$30B
$840K 0.01%
+18,979
New +$855K
IAS
156
DELISTED
Integral Ad Science
IAS
$823K 0.01%
+40,000
New +$823K
WDH
157
Waterdrop
WDH
$402M
$810K 0.01%
+125,000
New +$952K
ZY
158
DELISTED
Zymergen Inc. Common Stock
ZY
$800K 0.01%
+20,000
New +$789K
SKYT icon
159
SkyWater Technology
SKYT
$1.51B
$573K 0.01%
+20,000
New +$494K
FTH
160
Faeth Therapeutics
FTH
$729M
$449K 0.01%
2,300
DBTX
161
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$430K 0.01%
50,000
RAAS
162
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$424K 0.01%
16,667
AKYA
163
DELISTED
Akoya BioSciences
AKYA
$387K 0.01%
+20,000
New +$413K
RXRX icon
164
Recursion Pharmaceuticals
RXRX
$1.57B
$365K ﹤0.01%
+10,000
New +$296K
TRML
165
DELISTED
Tourmaline Bio
TRML
$343K ﹤0.01%
+2,333
New +$357K
TBIO
166
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$330K ﹤0.01%
+833
New +$294K
CVRX icon
167
CVRx
CVRX
$126M
$280K ﹤0.01%
+10,000
New +$280K
OMIC
168
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$275K ﹤0.01%
+333
New +$258K
TIL icon
169
Instil Bio
TIL
$48.4M
$251K ﹤0.01%
650
IMPL
170
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$221K ﹤0.01%
+25,000
New +$299K
BMEA icon
171
Biomea Fusion
BMEA
$90.4M
$156K ﹤0.01%
+10,000
New +$177K
RAIN
172
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$155K ﹤0.01%
+10,000
New +$175K
ACVA icon
173
ACV Auctions
ACVA
$1.35B
-75,000
Closed -$2.6M
AEE icon
174
Ameren
AEE
$31.5B
-707,089
Closed -$57.5M
ALHC icon
175
Alignment Healthcare
ALHC
$4.02B
-27,400
Closed -$601K

Similar funds

Zimmer Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Zimmer Partners held 242 positions worth $7.43B, up 0.87% from $7.37B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Zimmer Partners's Q2 2021 filing shows 74 new, 35 increased, 42 reduced and 70 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,083,049 shares worth $241M. The largest sale was Invitation Homes, an estimated $247M.

By sector, the portfolio is most concentrated in Real Estate at 33% of assets, down from 35% a quarter earlier, followed by Utilities and Communication Services.

  • Zimmer Partners's largest Q2 2021 buy was Apartment Income REIT Corp.: 5,083,049 shares worth $241M.
  • Zimmer Partners added most to Consolidated Edison in Q2 2021, an estimated $244M increase.
  • Zimmer Partners's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $247M.
  • Zimmer Partners fully exited Americold in Q2 2021, selling an estimated $204M.
  • Zimmer Partners's ten largest holdings make up 34% of its $7.43B portfolio in Q2 2021.
  • Zimmer Partners opened 74 new positions and closed 70 in Q2 2021.
  • Zimmer Partners's portfolio value rose 0.87% quarter-over-quarter to $7.43B.

Based on Zimmer Partners's 13F filing for Q2 2021, filed 16 Aug 2021.